U.S. Physical Therapy Dividendos y recompras

Dividendo controles de criterios 3/6

U.S. Physical Therapy es una empresa que paga dividendos con una rentabilidad actual de 1.81%. La fecha del próximo pago es en 6th December, 2024 con una fecha ex dividendo de 15th November, 2024.

Información clave

1.8%

Rentabilidad por dividendo

Rendimiento de la recompra

Rendimiento total para el accionista	1.8%
Rendimiento futuro de los dividendos	1.8%
Crecimiento de los dividendos	3.9%
Próxima fecha de pago de dividendos	06 Dec 24
Fecha ex dividendo	15 Nov 24
Dividendo por acción	€1.596
Ratio de pago	187%

Últimas actualizaciones de dividendos y recompras

Recent updates

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: El pago de dividendos de UPH ha sido volátil en los últimos 10 años.

Dividendo creciente: El pago de dividendos de UPH ha aumentado en los últimos 10 años.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de U.S. Physical Therapy vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de UPH con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (UPH)	1.8%
Suelo de mercado 25% (DE)	1.7%
Techo de mercado 25% (DE)	4.8%
Media de la industria (Healthcare)	2.7%
Analista de previsiones (UPH) (hasta 3 años)	1.8%

Dividendo destacado: El dividendo de UPH(1.81%) es más alto que el 25% inferior de los pagadores de dividendos del mercado German (1.73%).

Alto dividendo: El (1.81%) del dividendo de UPH es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado German (4.81%).

Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su elevado ratio de pago (186.7%), los pagos de dividendos de UPH no están bien cubiertos por los beneficios.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: Con su razonablemente bajo ratio de pago en efectivo (36.2%), los pagos de dividendos de UPH están bien cubiertos por los flujos de caja.

U.S. Physical Therapy Dividendos y recompras

Dividendo controles de criterios 3/6

Información clave

Últimas actualizaciones de dividendos y recompras

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

Upcoming dividend of US$0.43 per share at 1.6% yield

Recent updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock

Independent Director recently bought €54k worth of stock

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$0.82 in 2Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 16, 2022

U.S. Physical Therapy, Inc. to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.21 in 1Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 14, 2022

Insufficient new directors

U.S. Physical Therapy, Inc. to Report Q1, 2022 Results on May 05, 2022

U.S. Physical Therapy, Inc., Annual General Meeting, May 17, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others for $11.5 million.